Regeneron Pharmaceuticals (REGN) closed down more than -19% to lead losers in the S&P 500 and Nasdaq 100 after its itepekimab, an experimental drug jointly developed with Sanofi for chronic ...

Dr Sushil Kumar Sharma Each year on May 31, the World Health Organization (WHO) marks World No Tobacco Day to raise awareness ...

Facing erosion of its mighty Eylea (aflibercept) franchise and near-term loss of exclusivity with Dupixent (dupilumab), Regeneron Pharmaceuticals Inc. took a blow as one of two phase III trials with ...

In recent years, high ozone levels have been detected at Chatfield State Park, South Table Mountain in Golden, Boulder ...

xAI has come under scrutiny in recent months for operating methane gas turbines at its Memphis facility to meet the ...

Key Takeaways The S&P 500 slipped less than 0.1% on Friday, May 30, 2025, as President Trump rekindled his tough rhetoric on ...

Regeneron’s stock is having its worst day in 14 years after the failure of late-stage trial of its COPD treatment, after ...

Areas throughout the Midwest, including parts of Illinois, will see their air quality impacted by smoke from wildfires burning in Canada this weekend. The smoke is prompting several communities to ...

Regeneron and Sanofi face setbacks as itepekimab stumbles in phase 3. Click here to read why I believe SNY and REGN stocks ...

The placement places Ohio behind its neighboring states, Pennsylvania (11th) and Michigan (12th). Pennsylvania was ranked 11th for health care quality, eighth for health care access and 24th for ...

A new device was able to distinguish between mild and very severe chronic obstructive pulmonary disease (COPD).